Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula

Description

VasQ is an external support implant for arteriovenous fistulas created for dialysis access. This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms: * Treatment arm: End to side fistula supported with VasQ * Control: Standard of care end to side fistula

Conditions

End Stage Renal Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

VasQ is an external support implant for arteriovenous fistulas created for dialysis access. This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms: * Treatment arm: End to side fistula supported with VasQ * Control: Standard of care end to side fistula

Postmarket Surveillance, Prospective, Multicenter, Randomized, Controlled Study Evaluating the Performance of VasQ for Its Intended Use.

Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula

Condition
End Stage Renal Disease
Intervention / Treatment

-

Contacts and Locations

Greenwood

Greenwood Leflore Hospital, Greenwood, Mississippi, United States, 38930

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Patients who are candidates for the creation of a new radiocephalic or brachiocephalic end-to-side surgical AV fistula for dialysis access (per VasQ IFU and investigator clinical judgment) and consent to take part in the study.
  • 2. Male and non-pregnant female participants.
  • 3. Age 18-80 years
  • 4. Patients willing and able (physically and geographically) to attend follow up visits over a period of 12 months.
  • 1. Index procedure being a revision surgery of an existing fistula.
  • 2. Significantly stenotic target vein on the side of surgery (≥50%) as diagnosed on preoperative ultrasound. (Scan should include the full length of the expected fistula outflow, starting at the planned anastomosis site)
  • 3. Unusual anatomy or vessel dimensions (observed on pre-operative ultrasound or intraoperatively) and which preclude adequate fit of the VasQ.
  • 4. Known central venous stenosis or obstruction on the side of surgery.
  • 5. Pre-existing stents or stent grafts in the access circuit.
  • 6. Planned subsequent fistula superficialization procedure.
  • 7. Known coagulation disorder.
  • 8. Known allergy to nitinol.
  • 9. Expected kidney transplant within 12 months of enrollment.
  • 10. Inability to give consent and/or comply with the study follow up schedule.
  • 11. Insufficient or borderline life expectancy to allow for completion of study procedures and follow-up (12 Months).
  • 12. Participation in another interventional study that in the judgment of the investigator could confound study results.

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Laminate Medical Technologies,

John F Lucas III, MD, FACS, FSVS, PRINCIPAL_INVESTIGATOR, Greenwood Leflore Hospital

Study Record Dates

2028-05